scispace - formally typeset
S

Sebastian Bender

Researcher at Bayer

Publications -  53
Citations -  9565

Sebastian Bender is an academic researcher from Bayer. The author has contributed to research in topics: Cancer & DNA methylation. The author has an hindex of 29, co-authored 49 publications receiving 7950 citations. Previous affiliations of Sebastian Bender include German Cancer Research Center & Heidelberg University.

Papers
More filters
Journal ArticleDOI

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Dominik Sturm, +82 more
- 16 Oct 2012 - 
TL;DR: It is demonstrated that each H3F3A mutation defines an epigenetic subgroup of GBM with a distinct global methylation pattern, and that they are mutually exclusive with IDH1 mutations, which characterize a third mutation-defined subgroup.
Journal ArticleDOI

The landscape of genomic alterations across childhood cancers

Susanne Gröbner, +185 more
- 15 Mar 2018 - 
TL;DR: The data suggest that 7–8% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.
Journal ArticleDOI

Dissecting the genomic complexity underlying medulloblastoma

David T.W. Jones, +99 more
- 02 Aug 2012 - 
TL;DR: An integrative deep-sequencing analysis of 125 tumour–normal pairs enhances the understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provides several potential targets for new therapeutics, especially for Group 3 and 4 patients.
Journal ArticleDOI

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

David T.W. Jones, +82 more
- 01 Aug 2013 - 
TL;DR: Recurrent activating mutations in FGFR1 and PTPN11 and new NTRK2 fusion genes in non-cerebellar tumors and new BRAF-activating changes were observed, indicating that pilocytic astrocytoma is predominantly a single-pathway disease.